Literature DB >> 11778572

Understanding the diagnostic capabilities of cognitive tests.

R J Ivnik1, G E Smith, J H Cerhan, B F Boeve, E G Tangalos, R C Petersen.   

Abstract

Statistics (i.e., sensitivity, specificity, hit rates, positive and negative predictive values, odds ratios, and likelihood ratios) that best describe a diagnostic test's ability to classify persons as either "impaired" or "normal," but that are not commonly reported in neuropsychological research, are reviewed. These statistics are applied to Mayo Cognitive Factor Scale scores (MCFS; Smith et al., 1994) to demonstrate information that can be acquired about the diagnostic capabilities of cognitive tests as they are commonly used in clinical settings. Multivariate analyses then generated a statistical model that combines MCFS scores and improves on the diagnostic capabilities of the individual MCFS scores. This model enjoys better diagnostic power than individual scores. It establishes that cognitive testing that uses multiple measures is very good at differentiating normal from impaired cognitive states. Information is also provided that helps clinicians quantify a person's risk for cognitive impairment based on specific cognitive test score(s).

Entities:  

Mesh:

Year:  2001        PMID: 11778572     DOI: 10.1076/clin.15.1.114.1904

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  6 in total

1.  Testing the limits: cautions and concerns regarding the new Wechsler IQ and Memory scales.

Authors:  David W Loring; Russell M Bauer
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

2.  Diagnostic accuracy statistics for seven Neuropsychological Assessment Battery (NAB) test variables in the diagnosis of Alzheimer's disease.

Authors:  Brandon E Gavett; Katherine R Lou; Daniel H Daneshvar; Robert C Green; Angela L Jefferson; Robert A Stern
Journal:  Appl Neuropsychol Adult       Date:  2012       Impact factor: 2.248

3.  Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.

Authors:  Rabe E Alhurani; Maria Vassilaki; Jeremiah A Aakre; Michelle M Mielke; Walter K Kremers; Mary M Machulda; Yonas E Geda; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

4.  Validation of the NIH Toolbox in Individuals with Neurologic Disorders.

Authors:  N E Carlozzi; S Goodnight; K B Casaletto; A Goldsmith; R K Heaton; A W K Wong; C M Baum; R Gershon; A W Heinemann; D S Tulsky
Journal:  Arch Clin Neuropsychol       Date:  2017-08-01       Impact factor: 2.813

5.  Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trial.

Authors:  Bonnie C Sachs; Gordon J Chelune; Stephen R Rapp; Ashley M Couto; James J Willard; Jeff D Williamson; Kaycee M Sink; Laura H Coker; Sarah A Gaussoin; Tanya R Gure; Alan J Lerner; Linda O Nichols; Carolyn H Still; Virginia G Wadley; Nicholas M Pajewski
Journal:  Clin Neuropsychol       Date:  2021-09-01       Impact factor: 3.535

6.  The use of event-related potential (P300) and neuropsychological testing to evaluate cognitive impairment in mild traumatic brain injury patients.

Authors:  Puneet Nandrajog; Zamzuri Idris; Wan Nor Azlen; Alwani Liyana; Jafri Malin Abdullah
Journal:  Asian J Neurosurg       Date:  2017 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.